furazolidone has been researched along with Lung Diseases in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, JV | 1 |
| Thomas, AL | 1 |
| Cortez, LM | 1 |
| Pankey, GA | 1 |
2 other studies available for furazolidone and Lung Diseases
| Article | Year |
|---|---|
Pulmonary reaction to furoxone.
Topics: Adult; Drug Hypersensitivity; Furazolidone; Humans; Lung Diseases; Lymphocyte Activation; Male | 1973 |
Acute pulmonary hypersensitivity to furazolidone.
Topics: Acute Disease; Diarrhea; Furazolidone; Humans; Hydrocortisone; Lung Diseases; Male; Middle Aged; Rad | 1972 |